Pro Pharmaceuticals Group at Medicines Management 2025: Key Themes and Takeaways

Sandip Manku, Managing Director and Pharmacist at Pro Pharmaceuticals Group, attended Medicines Management 2025 (MM2025) on Friday 28 November.

It was an excellent opportunity to meet with our hospital customers, reconnect with colleagues across the pharmacy sector, and discuss the real-world pressures that medicine shortages continue to place on clinicians and patients nationwide.

One session that strongly aligned with our work highlighted several key themes:

• Most hospitals still do not receive automated shortage updates through their EHR or dispensing systems.

• Clinicians regularly face clinical change decisions due to shortages — switching to alternatives, modifying protocols, and managing risk.

• Shortages continue to disrupt bed flow, discharge processes, and patient care, especially in high-risk groups.

• Global supply chains remain fragile, with overreliance on a small number of API regions and declining manufacturing capacity in Europe.

These insights directly reinforce the purpose of what we do at Pro Pharmaceuticals Group:support hospitals through reliable access to unlicensed medicines, Section 19A supply pathways, and future AI-driven shortage intelligence.

With our ongoing development of tools like CheckMed and our internal Shortage Radar Agent, we are committed to giving hospitals faster visibility, better data, and more dependable supply options — especially when critical medicines are unavailable through usual channels.

MM2025 was a productive day of learning, networking, and strengthening partnerships. We look forward to applying these insights to continue supporting Australian hospitals and the patients who depend on them.